https://www.chdifoundation.org/roche-and-isis-pharmaceuticals-form-alliance-for-huntingtons-disease-2/2013-12-24T17:04:49-05:00https://www.chdifoundation.org/huntingtons-disease-therapeutic-and-companion-biomarker-collaboration-forged-by-kinemed-isis-pharmaceuticals-and-chdi-foundation-2/2014-02-19T16:05:02-05:00https://www.chdifoundation.org/chdi-foundation-continues-collaboration-with-medtronic-to-advance-sirna-therapeutics-to-treat-huntingtons-disease/2013-12-24T17:03:03-05:00https://www.chdifoundation.org/sangamo-biosciences-announces-first-presentation-of-data-from-zfp-therapeutic-for-huntingtons-disease-at-2012-annual-meeting-of-society-for-neuroscience/2013-12-24T17:06:06-05:00https://www.chdifoundation.org/proteome-sciences-to-collaborate-with-chdi-foundation-on-huntingtons-disease-research/2013-12-24T17:32:42-05:00https://www.chdifoundation.org/718/2013-12-24T17:36:55-05:00https://www.chdifoundation.org/thomson-reuters-partners-with-chdi-foundation-to-develop-systems-biology-tools-for-huntingtons-disease/2013-12-24T17:39:54-05:00https://www.chdifoundation.org/lundbeck-and-chdi-foundation-announce-research-collaboration-to-investigate-candidate-therapy-for-huntingtons-disease/2013-12-24T18:56:37-05:00https://www.chdifoundation.org/kinemed-and-chdi-foundation-collaborate-to-develop-new-biomarkers-of-disease-progression-and-to-evaluate-potential-therapeutics-for-huntingtons-disease/2013-12-24T19:01:03-05:00https://www.chdifoundation.org/galenea-and-chdi-foundation-announce-collaboration-to-identify-key-synaptic-dysfunction-in-huntingtons-disease-2/2013-12-24T19:04:46-05:00https://www.chdifoundation.org/isis-and-chdi-renew-collaboration/2013-12-24T19:07:06-05:00https://www.chdifoundation.org/cristina-sampaio-md-phd-joins-chdi-foundation-as-chief-clinical-officer-2/2013-12-24T19:10:37-05:00https://www.chdifoundation.org/chdi-and-fmi-collaboration/2013-12-24T19:12:47-05:00https://www.chdifoundation.org/sangamo-biosciences-and-chdi-foundation-announce-collaboration-to-develop-zfp-therapeutic-for-huntingtons-disease/2013-12-24T19:17:07-05:00https://www.chdifoundation.org/sagebionetworks-launches-international-neurobiology-partnerships/2013-12-24T19:44:59-05:00https://www.chdifoundation.org/chdi-foundation-inc-and-siena-biotech-spa-enter-collaboration-to-validate-novel-therapeutic-targets-for-huntingtons-disease/2013-12-24T19:47:16-05:00https://www.chdifoundation.org/enroll-hd-a-prospective-registry-study-in-a-global-hd-cohort/2013-12-24T19:50:07-05:00https://www.chdifoundation.org/alnylam-medtronic-and-chdi-foundation-form-collaboration-to-advance-rnai-therapeutics-for-the-treatment-of-huntingtons-disease/2013-12-24T20:40:00-05:00https://www.chdifoundation.org/the-public-library-of-science-with-support-from-chdi-foundation-inc-has-launched-plos-currents-huntington-disease/2013-12-24T20:43:47-05:00https://www.chdifoundation.org/chdi-foundation-inc-and-the-national-institute-of-neurological-disorders-and-stroke-ninds-launch-joint-program-to-support-the-validation-of-novel-therapeutic-targets-for-huntingtons-disease/2013-12-24T20:45:39-05:00https://www.chdifoundation.org/evotec-and-chdi-foundation-inc-extend-collaboration-to-fight-huntingtons-disease/2013-12-24T20:53:09-05:00https://www.chdifoundation.org/dotmatics-has-licensed-its-browser-and-vortex-solutions-to-chdi/2013-12-24T21:00:01-05:00https://www.chdifoundation.org/chdi-foundation-inc-to-carry-out-high-q-foundations-research-activities-in-huntingtons-disease/2013-12-24T21:05:53-05:00https://www.chdifoundation.org/under-renovation/2013-12-25T20:45:44-05:00http://ccr.coriell.org/Sections/Collections/CHDI/?SsId=45#new_tab2014-03-14T13:30:06-04:00http://currents.plos.org/hd/#new_tab2021-09-10T09:17:44-04:00https://enroll-hd.org/#new_tab2026-09-18T09:31:38-04:00https://www.chdifoundation.org/chdi-foundation-and-genzyme-enter-agreement-to-develop-novel-virally-delivered-gene-silencing-therapeutic-for-huntingtons-disease/2014-02-20T20:19:50-05:00https://www.chdifoundation.org/huntingtons-disease-society-of-america-endorses-enroll-hd/2014-02-21T15:15:06-05:00https://www.chdifoundation.org/a-field-guide-to-working-with-mouse-models-of-huntingtons-disease/2015-04-30T17:05:12-04:00https://chdifoundation.org/wp-content/uploads/HD_Field_Guide_040414.pdf#new_tab2021-09-09T09:50:15-04:00https://www.chdifoundation.org/video-postcard-from-2014-hd-therapeutics-conference/2014-03-26T12:34:59-04:00https://www.chdifoundation.org/choosing-an-animal-model-for-the-study-of-huntingtons-disease/2014-04-30T16:25:45-04:00https://www.chdifoundation.org/kinemed-and-chdi-foundation-extend-huntingtons-disease-collaboration/2014-05-20T10:11:58-04:00https://www.chdifoundation.org/structural-genomics-consortium-and-chdi-foundation-announce-open-access-collaboration-to-discover-new-drug-targets-for-huntingtons-disease/2014-06-10T14:14:20-04:00https://www.chdifoundation.org/discovery-research-and-systems-biology-leader-joins-chdi/2014-06-17T15:32:12-04:00https://www.chdifoundation.org/evotec-and-chdi-foundation-extend-ongoing-collaboration-to-fight-huntingtons-disease/2014-09-11T13:07:53-04:00https://www.chdifoundation.org/charles-rivers-early-drug-discovery-business-and-chdi-foundation-extend-huntingtons-disease-collaboration/2014-11-07T15:31:10-05:00https://chdifoundation.org/10th-annual-chdi-hd-therapeutics-conference/2015-03-03T13:50:45-05:00https://www.chdifoundation.org/10th-annual-chdi-hd-therapeutics-conference/2015-02-05T10:54:38-05:00https://www.chdifoundation.org/gns-healthcare-and-chdi-foundation-collaborate-to-identify-novel-drug-targets-for-huntingtons-disease/2014-11-12T10:29:11-05:00https://www.chdifoundation.org/autophagy-in-neurodegeneration-and-neuroprotection-a-therapeutic-perspective/2015-03-03T13:03:26-05:00https://chdifoundation.org/autophagy-in-neurodegeneration-and-neuroprotection-a-therapeutic-perspective/2015-04-29T12:45:57-04:00https://www.chdifoundation.org/new-assay-measures-pathogenic-protein-in-huntingtons-disease-patients-spinal-fluid/2015-04-08T12:26:36-04:00https://www.chdifoundation.org/video-postcard-from-2015-hd-therapeutics-conference/2015-04-29T12:45:07-04:00https://www.chdifoundation.org/isis-pharmaceuticals-initiates-clinical-study-of-isis-httrx-in-patients-with-huntingtons-disease/2015-07-21T16:43:15-04:00https://www.chdifoundation.org/11th-annual-chdi-hd-therapeutics-conference-2016/2016-02-29T16:02:30-05:00https://chdifoundation.org/11th-annual-chdi-hd-therapeutics-conference-2016/2016-05-11T17:56:56-04:00https://www.chdifoundation.org/video-postcard-from-2016-hd-therapeutics-conference/2016-09-01T17:48:07-04:00https://chdifoundation.org/video-postcard-from-2016-hd-therapeutics-conference/2016-08-30T14:34:51-04:00https://www.chdifoundation.org/voyager-therapeutics-and-chdi-foundation-collaborate-to-develop-novel-gene-therapy-for-huntingtons-disease/2016-09-12T10:49:01-04:00https://www.chdifoundation.org/critical-path-institute-and-chdi-foundation-inc-establish-a-consortium-to-expedite-approval-of-huntingtons-disease-therapeutics/2016-10-29T11:32:23-04:00https://www.chdifoundation.org/12th-annual-hd-therapeutics-conference-2/2017-05-11T15:24:37-04:00https://www.chdifoundation.org/voyager-therapeutics-selects-lead-clinical-candidate-for-huntingtons-disease/2017-06-01T11:45:20-04:00https://www.chdifoundation.org/enrollment-in-phase-12a-study-of-ionis-htt-rx-in-patients-with-huntingtons-disease-completed-and-open-label-extension-study-to-open-in-2h-2017/2017-06-22T10:22:38-04:00https://chdifoundation.org/wp-content/uploads/Pharmacodynamic-Biomarkers-white-paper.pdf#new_tab2021-09-20T14:44:33-04:00https://www.chdifoundation.org/hudsonalpha-and-chdi-foundation-announce-huntington-disease-collaboration/2017-08-30T14:25:24-04:00https://www.chdifoundation.org/c-path-chdi-foundation-and-cdisc-announce-public-review-period-for-huntingtons-disease-therapeutic-area-user-guide/2017-09-11T10:22:16-04:00https://www.hdinhd.org#new_tab2025-03-20T15:28:37-04:00https://www.chdifoundation.org/13th-annual-hd-therapeutics-conference/2018-02-20T11:03:20-05:00https://www.regonline.com/builder/site/?eventid=2064670#new_tab2018-03-28T12:25:46-04:00https://www.chdifoundation.org/ionis-pharmaceuticals-licenses-ionis-htt-rx-to-partner-following-successful-phase-12a-study-in-patients-with-huntingtons-disease/2017-12-11T11:53:59-05:00https://chdifoundation.org/all-postcards/2019-04-11T16:05:15-04:00https://www.chdifoundation.org/c-path-and-chdi-launch-consortium-to-accelerate-development-of-huntingtons-disease-therapies/2018-03-28T13:21:05-04:00https://www.chdifoundation.org/ptc-therapeutics-and-chdi-foundation-announce-a-collaboration-on-a-small-molecule-therapeutic-for-huntingtons-disease/2018-04-04T11:05:43-04:00https://www.chdifoundation.org/prime-designation-granted-by-european-medicines-agency-for-rg6042-for-treatment-of-huntingtons-disease/2018-10-30T13:49:05-04:00https://www.regonline.com/builder/site/Default.aspx?EventID=2541890#new_tab2019-04-11T16:06:32-04:00https://www.chdifoundation.org/evotec-and-chdi-foundation-extend-ongoing-collaboration-to-fight-huntingtons-disease-2/2018-08-29T12:09:49-04:00https://www.chdifoundation.org/c-path-chdi-and-cdisc-announce-therapeutic-area-user-guide-for-huntingtons-disease/2018-11-01T16:16:42-04:00https://www.chdifoundation.org/chdi-foundation-extends-collaboration-with-irbm-to-accelerate-development-of-huntingtons-disease-therapeutics/2018-11-16T10:59:10-05:00https://www.chdifoundation.org/new-enroll-hd-clinical-dataset-now-available/2018-12-19T13:43:35-05:00https://www.chdifoundation.org/charles-river-laboratories-and-chdi-foundation-extend-huntingtons-disease-collaboration/2019-09-05T12:55:15-04:00https://www.chdifoundation.org/huntingtons-disease-society-of-america-and-chdi-foundation-launch-hd-legacy-to-promote-brain-donation-for-hd-research/2019-09-05T12:55:39-04:00https://chdifoundation.org/15th-annual-huntingtons-disease-therapeutics-conference-in-palm-springs-california/2020-03-23T15:56:06-04:00https://www.chdifoundation.org/alex-borchers-phd-april-16-1961-august-3-2019/2020-03-16T17:37:15-04:00https://www.chdifoundation.org/a-letter-from-robert-pacifici-phd-chief-scientific-officer-chdi-to-our-collaborators-about-working-practices-during-the-pandemic/2020-03-16T17:45:07-04:00https://chdifoundation.org/2020-conference/2021-09-09T14:25:12-04:00https://chdifoundation.org/all-postcards/2021-09-09T12:29:46-04:00https://www.chdifoundation.org/molecular-design-platform-accelerating-research-for-huntingtons-disease/2020-07-30T10:31:53-04:00https://chdifoundation.org/16th-annual-hd-therapeutics-conference/#new_tab2021-09-10T09:16:56-04:00https://www.chdifoundation.org/alchemab-and-medicines-discovery-catapult-to-develop-landmark-novel-antibody-therapy-for-huntingtons-disease/2021-03-16T15:11:53-04:00https://chdifoundation.org/alchemab-and-medicines-discovery-catapult-to-develop-landmark-novel-antibody-therapy-for-huntingtons-disease/2021-03-16T15:11:34-04:00/all-postcards2022-07-07T14:04:14-04:00https://chdifoundation.org/2022-hdtc-announcement/#new_tab2022-04-01T10:55:47-04:00https://chdifoundation.org/2022-scientific-presentations-now-available/#new_tab2024-04-08T12:39:38-04:00/all-postcards/2022-07-08T15:50:07-04:00https://chdifoundation.org/2023-hdtc-announcement/2024-04-08T12:38:54-04:00https://www.chdifoundation.org/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/2022-09-21T16:49:17-04:00https://www.chdifoundation.org/european-medicines-agency-issues-qualification-opinion-that-enroll-hd-can-provide-data-and-infrastructure-support-for-post-authorization-monitoring-of-medical-products-for-huntingtons-disease/2025-05-15T14:51:26-04:00https://chdifoundation.org/about-us/2025-05-23T09:42:44-04:00https://www.chdifoundation.org/huntingtons-disease-image-harmonization-consortium-secures-new-member-and-funding-to-complete-large-scale-analysis-of-brain-changes-using-ixiq-ai/2025-05-15T14:50:33-04:00https://www.chdifoundation.org/huntington-study-group-and-chdi-foundation-collaborate-on-enroll-hd/2025-05-15T14:49:49-04:00https://chdifoundation.org/2024-hdtc/#new_tab2024-04-08T12:41:41-04:00https://www.chdifoundation.org/postcard-from-dubrovnik-2023/2024-05-14T14:31:32-04:00https://www.chdifoundation.org/postcard-from-palm-springs-2024/2025-05-15T11:30:55-04:00https://www.chdifoundation.org/evotec-and-chdi-foundation-extend-strategic-drug-discovery-collaboration-in-huntingtons-disease/2025-05-15T14:49:04-04:00https://chdifoundation.org/2025-scientific-presentations/2025-10-28T14:32:27-04:00https://www.chdifoundation.org/postcard-from-palm-springs-2025/2026-05-15T15:23:31-04:00https://chdifoundation.org/save-the-date-21st-annual-hd-therapeutics-conference-2026/#new_tab2026-03-19T15:42:48-04:00/wp-content/uploads/Prilenia-Donates-Clinical-Trial-Datasets-to-CHDI-Foundation-to-Advance-Huntingtons-Disease-Research.pdf#new_tab2026-06-02T10:08:33-04:00https://chdifoundation.org/22nd-annual-huntingtons-disease-therapeutics-conference/#new_tab2026-10-02T12:31:29-04:00